echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Deep brain stimulation of the hypothyroids of patients with obsessive compulsive disorder: an open, forward-looking, long-term follow-up of observational queues.

    JNNP: Deep brain stimulation of the hypothyroids of patients with obsessive compulsive disorder: an open, forward-looking, long-term follow-up of observational queues.

    • Last Update: 2020-10-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Obsessive compulsive disorder (OCD) is the main cause of disability in Western countries and a factor that seriously affects the quality of life.
    about 10% of patients with severe obsessive compulsive disorder require innovative medical treatments such as deep brain stimulation (DBS).
    possible targets, the non-motoric hypothyroidism (STN) is a key node in the substrate neural circuit, closely linked to the marginal cortical region associated with obsessive compulsive disorder (OCD).
    method: The effects of chronic non-motor stN-DBS treatment in 19 patients with resoccurring obsessive compulsive disorder (OCD) were analyzed by using forward-looking, observational, single-center, open cohort study method.
    the severity of obsessive-compulsive disorder was assessed using the Yale and Brown obsessive-compulsive scales (YBOCS).
    YBOCS scores compared with baselines for 6, 12, and 24 months after surgery.
    respondents were determined by the YBOCS score improvement of 35%.
    Global Assessment Function (GAF) scale is used to assess the impact of improvements.
    results: 24 months of follow-up, YBOCS score increased from 33.3±3.5 to 15.8±9.1, an increase of 53.4% (95% CI 11.2-20.4; p.lt;0.0001).
    14 of the 19 patients were considered effective, 5 of the 19 cases improved by more than 75% and 10 cases by more than 50%.
    GAF rating increased from 34.1±3.9 to 66.4±18.8 (95% CI 56.7-76.1; p-0.0003), an increase of 92%.
    most common adverse events include transient anxiety and mild anxiety.
    : Non-motor STN chronic DBS is an effective and relatively safe method for treating severe obsessive compulsive disorder, which is resistant to conventional treatment.
    Chabardes S, Krack P, Piallat B, et al Deep brain stimulation of the subthalamic nucleus in obsessive-compulsives disorders: long-term follow-up of an open, Prospective, observational cohort Journal of Neurology, Neurosurgery and Psimsy Published Online First: 08 October 2020. doi: 10.1136/jnnp-2020-323421MedSci Original Source: MedSci Original Copyright Statement: All noted on this website "Source: Mets Medicine" or "Source: MedSci Original." "The copyrights to the text, images and audio-visual materials shall be owned by Metz Medicine and shall not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Metz Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.